Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders
出版年份 2023 全文链接
标题
Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders
作者
关键词
-
出版物
International Journal of Environmental Research and Public Health
Volume 20, Issue 8, Pages 5430
出版商
MDPI AG
发表日期
2023-04-07
DOI
10.3390/ijerph20085430
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation
- (2023) Berhanu Geresu Kibret et al. Frontiers in Behavioral Neuroscience
- Global prevalence of autism: A systematic review update
- (2022) Jinan Zeidan et al. Autism Research
- A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ
- (2022) Aviad Schnapp et al. Biomedicines
- A natural history study of medical cannabis consumption in pediatric autism in the United States
- (2022) Mary Ann DiLiberto et al. Research in Autism Spectrum Disorders
- Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study
- (2022) Micha Hacohen et al. Translational Psychiatry
- A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)
- (2022) Elizabeth Berry-Kravis et al. Journal of Neurodevelopmental Disorders
- Cannabis use in Attention – Deficit/Hyperactivity Disorder (ADHD): A scoping review
- (2022) Ana Paula Francisco et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Cannabinoid treatment for autism: a proof-of-concept randomized trial
- (2021) Adi Aran et al. Molecular Autism
- Cannabidiol for at risk for psychosis youth: A randomized controlled trial
- (2021) G. Paul Amminger et al. Early Intervention in Psychiatry
- Pharmacological treatment for Tourette syndrome in children and adults: What is the quality of the evidence? A systematic review
- (2021) Frank MC Besag et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pharmacokinetics and perceptions of children and young adults using Cannabis for ADHD and ODD: A Mixed-Methods Proof-of-Concept Study (Preprint)
- (2021) Holly Mansell et al. JMIR Research Protocols
- Self-Reported Effects of Cannabis on ADHD Symptoms, ADHD Medication Side Effects, and ADHD-Related Executive Dysfunction
- (2021) Amanda Stueber et al. Journal of Attention Disorders
- Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder
- (2021) Erica Zamberletti et al. PHARMACOLOGY & THERAPEUTICS
- Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
- (2020) Jerome Sarris et al. BMC Psychiatry
- Association of a Variant of CNR1 Gene Encoding Cannabinoid Receptor 1 With Gilles de la Tourette Syndrome
- (2020) Natalia Szejko et al. Frontiers in Genetics
- Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial
- (2020) Charlie Fairhurst et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome
- (2020) Kirsten R. Müller-Vahl et al. NEUROPSYCHOPHARMACOLOGY
- Does cannabidiol reduce severe behavioural problems in children with intellectual disability? Study protocol for a pilot single-site phase I/II randomised placebo controlled trial
- (2020) Daryl Efron et al. BMJ Open
- Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
- (2020) Umberto Raucci et al. Frontiers in Pharmacology
- Clinical trials with cannabis medicines—guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience
- (2020) Jennifer H. Martin et al. Trials
- Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
- (2019) Lihi Bar-Lev Schleider et al. Scientific Reports
- Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities
- (2019) Dana Barchel et al. Frontiers in Pharmacology
- A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome
- (2019) Helen Heussler et al. Journal of Neurodevelopmental Disorders
- Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use
- (2019) Paulo Fleury-Teixeira et al. Frontiers in Neurology
- Medical cannabis for paediatric developmental-behavioural and psychiatric disorders
- (2018) Daryl Efron et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- Compassion and evidence in prescribing cannabinoids: a perspective from the Royal Australasian College of Physicians
- (2018) Jennifer H Martin et al. MEDICAL JOURNAL OF AUSTRALIA
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
- (2018) A. Suraev et al. Scientific Reports
- Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis
- (2018) Sagnik Bhattacharyya et al. JAMA Psychiatry
- Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders
- (2018) Heather K. Hughes et al. Frontiers in Cellular Neuroscience
- Cannabidiol as a suggested candidate for treatment of autism spectrum disorder
- (2018) Shani Poleg et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients
- (2017) Ewgeni Jakubovski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Medication prescribed by Australian paediatricians: Psychotropics predominate
- (2017) Daryl Efron et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Medical Cannabinoids in Children and Adolescents: A Systematic Review
- (2017) Shane Shucheng Wong et al. PEDIATRICS
- Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study
- (2017) Rory Sheehan et al. BMJ Open
- Psychotropic prescribing in people with intellectual disability and challenging behaviour
- (2017) Rory Sheehan et al. BMJ-British Medical Journal
- Psychotropic prescribing in people with intellectual disability and challenging behaviour
- (2017) Rory Sheehan et al. BMJ-British Medical Journal
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies
- (2016) Nicholas J. Jackson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- “I Use Weed for My ADHD”: A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD
- (2016) John T. Mitchell et al. PLoS One
- Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
- (2015) Craig A. Press et al. EPILEPSY & BEHAVIOR
- Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
- (2015) Ryan Vandrey et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endocannabinoid Signaling in Autism
- (2015) Bhismadev Chakrabarti et al. Neurotherapeutics
- Cannabidiol as a Potential Treatment for Anxiety Disorders
- (2015) Esther M. Blessing et al. Neurotherapeutics
- ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis
- (2014) Guilherme V Polanczyk et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Current Australian Pediatric Practice in the Assessment and Treatment of ADHD
- (2013) Daryl Efron et al. Academic Pediatrics
- Trends in the Parent-Report of Health Care Provider-Diagnosed and Medicated Attention-Deficit/Hyperactivity Disorder: United States, 2003–2011
- (2013) Susanna N. Visser et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
- (2013) Csaba Földy et al. NEURON
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Oral Δ9-Tetrahydrocannabinol Improved Refractory Gilles de la Tourette Syndrome in an Adolescent by Increasing Intracortical Inhibition
- (2010) Alkomiet Hasan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns
- (2009) Benedetto Vitiello et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started